v3.26.1
STOCK APPRECIATION RIGHTS LIABILITY
3 Months Ended
Mar. 31, 2026
Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]  
STOCK APPRECIATION RIGHTS LIABILITY

14. STOCK APPRECIATION RIGHTS LIABILITY

 

Effective May 15, 2023, the Company issued 1,500,000 stock appreciation rights (the “Smallwood SARs”) to Brady Smallwood, its former Chief Operating Officer (“COO”). The Smallwood SARs were valued utilizing the Black-Scholes valuation model, and had an aggregate fair value of $9,794 upon issuance; this amount was charged to operations and credited to stock appreciation rights liability. The Smallwood SARs are revalued each quarter, and any gain or loss in the fair value is charged to non-cash compensation expense.

 

During the three months ended March 31, 2026 and 2025, Smallwood SARs decreased in fair value in the amount $15,410 and $60,595, respectively; these amounts were charged to non-cash compensation. At March 31, 2026 and December 31, 2025, the Smallwood SARs had a fair value of $733 and $16,143, respectively.

 

The change in valuation of the Smallwood SARs is summarized in the table below:

 

May 15, 2023 - fair value  $9,794 
Loss on revaluation   245,226 
December 31, 2023 -fair value  $255,020 
Loss on revaluation   1,098,130 
December 31, 2024 - fair value  $1,353,150 
Gain on revaluation   (1,337,007)
December 31, 2025 - fair value  $16,143 
Gain on revaluation   (15,410)
March 31, 2026 - fair value  $733 

     

The Smallwood SARs were valued using the Black-Scholes valuation model utilizing the following variables:

 

   March 31,   December 31, 
   2026   2025 
Volatility   66.47%   77.84-205.63%
Dividends   0%   0%
Risk-free interest rates   3.68%   3.48-4.10%
Term (in years)   0.75    1.00-2.00 

 

The price of the Company’s common stock on the date of the grant of the Smallwood SARs was $0.41. The exercise prices at the dates of the grants were $1.50 and $2.00.